Positron emission tomography;Positronen-emissions-tomographie

Zeitschrift fur Kardiologie

Volumn 89, Issue SUPPL. 1, 2000, Pages 59-66

  Schwaiger, Markus ^a   Pirich, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary flow; Neuronal innervation; Positron emission tomography; Viability

Indexed keywords

CARBON 11; EPHEDRINE DERIVATIVE; HYDROXYEPHEDRINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART INNERVATION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SYMPATHETIC TONE;

CORONARY CIRCULATION; CORONARY DISEASE; HEART; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PROGNOSIS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033951655     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Bax JJ, Visser FC, Blanksma PK et al. (1996) Comparison of myocardial uptake of fluorine-18 fluorodesoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 37: 1631-1636
2. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD (1998) Delay in revascularisation is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98: (suppl) 1151-56
3. Beanlands RSB, Muzik O, Melon P, Sutor R, Sawada S, Muller D, Bondie D, Hutchins GD, Schwaiger M (1995) Non-invasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. J Am Coll Cardiol 26: 1465-1475
4. Bengel FM, Ueberfuhr P, Ziegler S, Nekolla S, Reichart B, Schwaiger M (1999) Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 Hydroyephedrine. Circulation 99: 1866-1871
5. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL (1991) Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodesoxyglucose. Circulation 83: 26-37
6. Brown BG, Zhao XQ, Sacco DE, Albers JJ (1993) Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87: 1781-1791
7. Brunken R, Tilisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M et al. (1986) Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q-wave infarction: evidence for persistence of viable tissue in some regions ba positron emission tomography. Circulation 73: 951-963
8. Camici P, Ferranini E, Opie LH (1989) Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32: 217-238
9. Czernin J, Sun K, Brunken R, Bottcher M, Phelps M, Schelbert H (1995) Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 91: 2891-2897
10. Czernin J, Barnard RJ, Sun KT et al. (1995) Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow-reserve. Circulation 92: 197-204
11. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR (1993) Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88: 62-69
12. vom Dahl J, Eitzman DT, al-Aouar AR et al. (1994) Relation of regional function, perfusion, and metabolism in patients with-advanced coronary artery disease undergoing surgical revascularization. Circulation 90: 2356-2366
13. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M (1994) Early detection of abnormal coronary flow reserve in asymptomatic measure at high risk for coronary artery disease using positron emission tomography. Circulation 90: 808-817
14. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME (1989) Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients. Circulation 79: 825-835
15. DiCarli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR (1995) Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 91: 1944-1951
16. DiCarli MF, Davidson M, Little R et al. (1994) Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73: 527-533
17. DiCarli MF, Asgarzade F, Schelbert HR et al. (1995) Quantitative relation between myocardial viability and improvement in hear failure symptoms after revascularization in patients with ischemic cardiomyopathy. Cirulation 92: 3436-3444
18. Eitzmann D, Al-Aour Z, Kanter H, vom Dahl J, Kirsh M, Deeb GM et al. (1992) Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20: 559-565
19. Engemeier RS, O'Connell JB, Walsh R et al. (1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo controlled trial. Circulation 72: 536-546
20. Go TR, Marwick TH, MacIntyre WJ et al. (1990) A prospective comparison of rubudium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 31: 1899-1905
21. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ (1994) Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole on patients with coronary artery disease. Circulation 89: 1530-1538
22. Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M (1999) Delayed response of myocardial flow reserve to lipid lowering therapy with fluvastatin. Circulation 99: 475-481
23. Gropler RJ, Siegal BA, Lee KJ et al. (1990) Nonuniformity in myocardial accumulation of F-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 31: 1749-1756
24. Haas F, Haehnel CJ, Picker W et al. (1997) Perioperative PET viability assessment and peri-and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30: 1693-1700
25. Hicks K, Ganti G, Mullani N, Gould K (1989) Automated quantitation of three-dimensional cardiac positron emission tomography for routine clinical use. J Nucl Med 30: 1787-1797
26. Huggins GS, Pasternak RC. Alpert NM, Fischmann AJ, Gewirtz H (1998) Effects of short-term treatment of Hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve. Circulation 98: 1291-1296
27. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE (1990) Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15: 1032-1042
28. Kalff V, Schwaiger M, Nguyen N, McClanahan TB, Gallagher K (1992) The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with F-18 deoxyglucose. J Nucl Med 33: 1346-1353
29. Laubenbacher C, Rothley J, Sitomer J et al. (1993) An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localisation of coronary artery disease using nitrogen 13-ammonia. J Nucl Med 34: 968-978
30. Lee K, Marwick T, Cook S, Go RT, Fix JS, James KB et al. (1994) Prognosis of left ventricular dysfunction with and without viable myocardium after myocardial infarction. Circulation 90: 735-745
31. Lucignani G, Paolini G, Landoni C et al. (1992) Presurgical identification of hibernating myocardium by combined use of technetium-99m hexokinase 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxyglucose positron emission tomography in patients with coronary artery disease. Europ J Nucl Med 19: 874-881
32. Maddahi J, DiCarli M, Davidson M et al. (1992) Prognostic significance of PET assessment of myocardial viability in patients with left ventricular dysfunction. J Am Coll Cardiol 19: 142A
33. MAAS investigators (1994) Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 344: 633-638
34. Merlet P, Valette H, Dubois-Rande J et al. (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33: 471-477
35. Nekolla S, Schlieringer S, Stadler E, Schwaiger M (1996) World wide web and virtual reality markup language extensions in cardiac SPECT and PET data processing. J Nucl Med 37: 172P
36. Packer M, Bristow MR, Cohn JN et al. (1996) The effect of carvediol on morbidity and mortality in patients with chronic-heart failure. N Engl J Med 334: 1349-1355
37. Pitkanen OP, Raitakari OT, Ronnemaa T, Niinikoski H, Nuutila P, Lida H, Viikari JS, Knuuti J (1997) Influence of coronary risk status on coronary flow reserve in healthy young men. Am J Cardiol 79: 1690-1692
38. Porenta G, Kuhle W, Czernin J et al. (1992) Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET. J Nucl Med 33: 1628-1636
39. Sacks FM, Pfeffer MA, Moye LA et al. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N-Engl-J-Med 335: 1001-1009
40. Sandler MP, Videlefsky S, Delbeke D et al. (1995) Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 fluorodesoxyglucose/technetium-99m-MIBI and dual-isotope simultaneous-acquisition single photon emission computed tomography. J Am Coll Cardiol 26: 870-876
41. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Trial (4S). Lancet 344: 1383-1389
42. Schelbert HR, Phelps ME, Hoffman EJ, Huang S, Selin CE (1979) Regional myocardial perfusion assessed with N-13 ammonia and positron emission computerized axial tomography. Am J Cardiol 43: 209-218
43. Schelbert HR, Henze E, Phelps ME, Kuhl DE (1982 Assessment of regional myocardial ischemia by positron emission computed tomography. Am Heart J 103: 588-597
44. Schelbert HR (1994) Merits and limitations of radionuclide approaches to viability and future developments. J Nucl Cardiol 1: S86-96
45. Schoen H, Schelbert HR, Najafi A et al. (1982) C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography: II Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Am Heart J 1103: 548-561
46. Schwaiger M, Brunken R, Grover McKay M, Krivokapich J, Child J, Tillisch JH, Phelps ME, Schelbert HR (1986) Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 8: 800-808
47. Schwaiger M, Fishbein MC, Block M et al. (1987) Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: non-invasive assessment by positron emission tomography. J Mol Cell Cardiol 19: 259-269
48. Schwaiger M, Hutchins G, Rosenspire K, Haka M, Wieland DM (1990) Quantitative evaluation of the sympathetic nervous system by PET in patients with cardiomyopathy. J Nucl Med 31: 792
49. Schwaiger M, Schelbert HR, Ellison D et al. (1985) Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 6: 336-347
50. Schwaiger M, Ziegler S (1998) Positron emission tomography. In: Topol EJ (ed) Textbook of cardiovascular medicine. Chapter 52, pp 1447-1468
51. Sheperd J, Cobbe SM, Ford I et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
52. Tamaki N, Othani H, Yamashity K et al. (1991) Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 32: 673-678
53. Tamaki N, Yonekura Y, Yamashita K et al. (1993) Prognostic value of an increase in Fluorine-18 Deoxyglucose uptake in patients with myocardial infarction. Comparison with stress thallium imaging. J Am Coll Cardiol 22: 16721-1627
54. Tilisch J, Brunken R, Marshall R et al. (1986) Reversibility of cardiac wall motion abnormalities predicted by positron emission tomography. N Engl J Med 314: 884-888
55. Uren NG, Melin JA, DeBruyne B, Wijns W, Baudhuin T, Camici PC (1994) Relation between myocardial blood flow and the severity of coronary artery sternosis. N Engl J Med 330: 1782-1788
56. Vanoverschelde JL, Wijins W, Depre C et al. (1993) Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of non-infarcted collateral-dependent myocardium. Circulation 87: 1513-1523
57. Wolpers HG, Koster C, Burchert W et al. (1995) Coronary reserve after orthotopic heart transplantation: quantification with N-13 ammonia and positron emission tomography. Z Kardiol 84: 112-120
58. Yoshida K, Gould L (1993) Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularisation. J Am Coll Cardiol 22: 984-997
59. Zhao XM, Delbeke D, Sandler MP et al. (1995) Nitrogen 13-ammonia and PET to detect allograft coronary artery disease after heart transplantation: comparison with coronary angiography. J Nucl Med 36: 982-987